Mark Anliker
Overview
Explore the profile of Mark Anliker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cazzaniga S, Ballmer-Weber B, Grani N, Spring P, Bircher A, Anliker M, et al.
Contact Dermatitis
. 2018 Jun;
79(3):136-148.
PMID: 29943397
Background: Hand eczema (HE) is common and may follow a chronic disease course. So far, prospective studies investigating the risk factors for disease progression as a prerequisite for targeted prevention...
2.
Kolios A, Gubeli A, Meier B, Maul J, Kundig T, Nilsson J, et al.
Dermatology
. 2017 Nov;
233(4):268-276.
PMID: 29130957
Background/aim: Pyoderma gangrenosum (PG) is a rare, neutrophilic dermatosis often associated with an underlying disease, and clinical data or larger studies are rare. Methods: In this retrospective study, disease characteristics,...
3.
Jungo P, Maul J, Djamei V, von Felten S, Kolios A, Czernielewsk J, et al.
Dermatology
. 2017 Jan;
232(6):655-663.
PMID: 28103601
Background: Randomized controlled trials have shown the efficacy of systemic treatments in moderate-to-severe psoriasis. Clinical outcomes in psoriasis patients under real-world conditions are less well understood. Objective: This study compared...
4.
Maul J, Djamei V, Kolios A, Meier B, Czernielewski J, Jungo P, et al.
Dermatology
. 2017 Jan;
232(6):640-647.
PMID: 28076860
Background: The Swiss psoriasis registry SDNTT (Swiss Dermatology Network for Targeted Therapies) records the long-term safety and effectiveness of systemic treatment regimens for psoriasis. Patients And Methods: Patients with moderate...
5.
Kolios A, Yawalkar N, Anliker M, Boehncke W, Borradori L, Conrad C, et al.
Dermatology
. 2016 Jun;
232(4):385-406.
PMID: 27322375
Psoriasis vulgaris is a common, chronic inflammatory skin disease with a prevalence of 1.5-2% in Western industrialized countries. A relevant percentage of patients suffer from moderate-to-severe psoriasis and experience a...
6.
Hofbauer G, Anliker M, Boehncke W, Brand C, Braun R, Gaide O, et al.
Swiss Med Wkly
. 2014 Dec;
144:w14026.
PMID: 25539459
Actinic keratosis (AK) affects millions of people worldwide, and its prevalence continues to increase. AK lesions are caused by chronic ultraviolet radiation exposure, and the presence of two or more...
7.
Shafaeddin Schreve B, Anliker M, Arnold A, Kempf W, Laffitte E, Lapointe A, et al.
Curr Probl Dermatol
. 2012 Mar;
43:57-70.
PMID: 22377920
Solid organ transplant recipients (SOTR) have an increased risk of skin cancer due to their long-term immunosuppressive state. As the number of these patients is increasing, as well as their...
8.
Hundsberger T, Cogliatti S, Kleger G, Fretz C, Gahler A, Anliker M, et al.
Case Rep Neurol
. 2011 Nov;
3(3):278-83.
PMID: 22125529
Ischemic stroke is a serious disease leading to significant morbidity and mortality. Multifocal and recurrent strokes are usually caused by embolic diseases, i.e. atrial fibrillation, but rare causes like cerebral...
9.
Gough J, Anliker M, Spieth M, Kasner D
Clin Med Res
. 2005 Jun;
2(1):55-8.
PMID: 15931335
Introduction: As the number of radioisotope localization cases increased at our facility, the pathologists expressed concern regarding radiation exposure from parathyroid specimens. The radiation safety officer was consulted to analyze...